450330.KQ HASS Corp

Healthcare Medical Instruments & Supplies KOSDAQ
3,975 KRW
Close of Nov 1, 2026
3,650 8,700
Market cap
KRW 30.8B
P/E
-
P/B
0.74x
ROE
-7.1%
Dividend yield
1.78%
Fundamental score
2.0/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 450330.KQ undervalued?

Graham number

The Graham number of HASS Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

HASS Corp fundamental analysis

9 of 21 checks passed

ROE 0/2

Low return on equity (-7.1%), below 10%.

ROA 0/1

Return on assets (-5.9%) is below the industry median (-2.3%).

Profit Consistency 2/2

Profitable for 5 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (-13.6%) is above the industry median (-27.9%).

Revenue Growth 1/2

Revenue grew 3.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (2.9%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Cash Runway 0/2

Cash covers 0.7 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.7x) is below the industry median (1.2x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.8%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 35.4%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

HASS Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About HASS Corp

Hass Corp. manufactures and sells dental medical devices. Its CAD/CAM systems include Amber Mill, a machinable dental glass-ceramic blocks made of lithium disilicate; Amber Mill Direct, a CAD/CAM-based millable lithium disilicate block; Amber Mill H, a CAD/CAM block using nano-crystalline ceramics particle; Amber Mill Q, an implant abutment solution; and Amber Mill Meso, a lithium disilicate-based block for implant prosthese. The company's heat-pressing systems comprise Ambe…

Full company profile